Biomedical Science Letters (대한의생명과학회지)

The Korean Society for Biomedical Laboratory Sciences (대한의생명과학회)
권호 표지

Immunohistochemical Changes of Apoptotic Control Genes by Chronic Inhibition of Nitric Oxide in Rats

  • Bae, Hyung-Joon (Department of Clinical Laboratory Science, Hyecheon College)
  • Received : 2012.08.26
  • Accepted : 2012.10.12
  • Published : 2012.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Sprague-Dawley (SD) rats were orally administered with NG-nitro-L-arginine methyl ester (L-NAME), which inhibits or blocks the production of nitric oxide from L-arginine in vascular endothelial cells and vessel tissue. We examined the effects of nitric oxide on some physiological changes such as blood pressure and heart rate, and confirms the apoptosis induced by the suppressed nitric oxide activity in the kidney. This study was performed to investigate correlation between the activities of nitric oxide and apoptosis by immunohistochemical changes of apoptotic control proteins with regulated chronic inhibition of nitric oxide. In the kidney from L-NAME-treated group, immunohistochemical reaction to the antigens of apoptosis inhibiting proteins such as bcl-2 and bcl-xL, exhibited a time-dependent reduction. The expression of apoptosis-inhibiting proteins such as bax and p53 increased expression in proportion to the duration of treatment. The most sensitive apoptosis regulating proteins to L-NAME were p53 in stimulation and bcl-2 in inhibition, respectively.

Keywords

References

  1. Amore A, Emancipator SN, Cirina P, Conti G, Ricotti E, Bacheri N, Coppo R. Nitric oxide mediate cyclosporine-induced apoptosis in cultured renal cells. Kidney Int. 2000. 57: 1549-1559. https://doi.org/10.1046/j.1523-1755.2000.00999.x
  2. Antonsson B. Mitochondria and the bcl-2 family proteins in apoptosis signaling pathways. Mol Cell Biochem. 2004. 256: 141-155. https://doi.org/10.1023/B:MCBI.0000009865.70898.36
  3. Brune B, von Knethen A, Sandau KB. Nitric oxide (NO): an effector of apoptosis. Cell Death Differ. 1999. 6: 969-975. https://doi.org/10.1038/sj.cdd.4400582
  4. Bursch W, Taper HS, Lauer B, Schulte-Hermann R. Quantiative histological and histochemical studies on the occurrence and stages of controlled cell death (apoptosis) during regression of rat liver hyperplasia. Virchows Arch B Cell Pathol Incl Mol Pathol. 1985. 50: 153-166.
  5. Cotran R, Kumar SV, Robbins SL. Pathologic basis of disease. 5th ed. 1994. pp 17-21, WB Saunders Co. Philadelphia, USA.
  6. Chung MJ, Jang KY, Kang MJ, Lee DG, Oh BC. Expression of apoptosis, bcl-2, and PCNA in uterine cervical intraepithelial neoplasia and invasive carcinoma. Kor J Pathol. 1997. 31: 1180-1189.
  7. Delchev SD, Georgieva KN, Koeva YA, Atanassova PK. Bcl-2/ Bax ratio, mitochondrial membranes and aerobic enzyme activity in cardiomyocytes of rats after submaximal training. Folia Med. 2006. 48: 50-56.
  8. Dimmeler S, Haendeler J, Nehls M, Zeiher AM. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1-betaconverting enzyme(ICE)-like and cysteine protease protein (CPP)-32-like proteases. J Exp Med. 1997. 185: 601-607. https://doi.org/10.1084/jem.185.4.601
  9. Erdely A, Freshour G, Baylis C. Resistance to renal damage by chronic nitric oxide synthase inhibition in the Wistar-Furth rat. Am J Physiol Intergr Comp Physiol. 2006. 290: R66-72. https://doi.org/10.1152/ajpregu.00444.2005
  10. Genaro AM, Hortelano S, Alvarez A, Martinez C, Bosca L. Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J Clin Invest. 1995. 95: 1884-1890. https://doi.org/10.1172/JCI117869
  11. Hebestreit H, Dibbert B, Balatti I, Braun D, Schpowal A, Blaser K, Simon HU. Disruption of fat receptor signaling by nitric oxide in eosinophils. J Exp Med. 1998. 187: 415-425. https://doi.org/10.1084/jem.187.3.415
  12. Hockenbery D. Defining apoptosis. Am J Pathol. 1995. 146: 16-19.
  13. Jacobsen MD. Apoptosis: bcl-2-related proteins get connected. Curr Biol. 1997. 7: 277-281. https://doi.org/10.1016/S0960-9822(06)00124-2
  14. Kaneto H, Fujii J, Seo HG, Suzuki K, Matsuoka T, Nakamura M, Tatsumi H, Yamasaki Y, Kamada T, Taniguchi N. Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells. Diabetes. 1995. 44: 733-738. https://doi.org/10.2337/diabetes.44.7.733
  15. Kim YM, de Vera ME, Watkins SC, Billiar TR. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factoralpha- induced apoptosis by inducing heat shock protein 70 expression. J Biol Chem. 1997. 272: 1402-1411. https://doi.org/10.1074/jbc.272.2.1402
  16. Kroemer G. The proto-oncogene bcl-2 and lits role in regulating apoptosis. Nature Med. 1997. 3: 614-620, https://doi.org/10.1038/nm0697-614
  17. Levine AJ, Momand J, Finlay C. The p53 tumor suppressor gene. Natur. 1991. 351: 453-456. https://doi.org/10.1038/351453a0
  18. Liu L, Stamler JS. NO: an ingibitor of cell death. Cell Death Differ. 1999. 6: 937-942. https://doi.org/10.1038/sj.cdd.4400578
  19. Mannick JB, Asano K, Izumi K, Kieff E, Stamler JS. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell. 1994. 79: 1137-1146. https://doi.org/10.1016/0092-8674(94)90005-1
  20. Muhl H, Sandau K, Brune B, Briner VA, Pfeilschifier J. Nitric oxide donors induce apoptosis in glomerular mesengial cells, epithelial cells and endothelial cells. Eur J Pharmacol. 1996. 317: 137-149. https://doi.org/10.1016/S0014-2999(96)00701-7
  21. Nicotera P, Brune B, Bagetta G. Nitric oxide: inducer of suppressor of apoptosis? Trends Pharmacol Sci. 1997. 18:189-190.
  22. Nishio E, Watanabe Y. Nitric oxide donor-induced apoptosis in smooth muscle cells is modulated by protein kinase. A Eur J Pharmacol. 1997. 339: 245-251. https://doi.org/10.1016/S0014-2999(97)01368-X
  23. Pabla N, Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int. 2008. 73: 994-1007. https://doi.org/10.1038/sj.ki.5002786
  24. Prasad R, Vaid M, Katiyar SK. Grape proanthocyanidin inhibit pancreatic cancer cell growth in vitro and in vivo through induction of apoptosis and by targeting the PI3K/Akt pathway. PLoS One. 2012. 7: e43064. https://doi.org/10.1371/journal.pone.0043064
  25. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol. 1994. 124: 1-6. https://doi.org/10.1083/jcb.124.1.1
  26. Rodriguez AM, Flores O, Martinez-Salgado C, Eleno N, Lopez- Novoa JM, Arevalo M. Increased apoptosis susceptibility in mesangial cells from spontaneously hypertensive rats. Microvasc Res. 2000. 59: 80-87. https://doi.org/10.1006/mvre.1999.2197
  27. Salvesen GS, Dixit VM. Caspases: intracellular signaling by proteolysis. Cell. 1997. 91: 443-446. https://doi.org/10.1016/S0092-8674(00)80430-4
  28. Sandau K, Pfeilschifter J, Brune B. Nitric oxide and superoxide induced p53 and Bax accumulation during mesangial cell apoptosis. Kidney Int. 1997. 52: 378-386. https://doi.org/10.1038/ki.1997.344
  29. Susin SA, Zamzami N, Castedo M, Daugas E, Wang HG, Geley S, Fass;y F, Reed JC, Kroemer G. The central execution of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95 and ceramide-0induced apoptosis. J Exp Med. 1997. 186: 25-37. https://doi.org/10.1084/jem.186.1.25
  30. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995. 267: 1456-1462. https://doi.org/10.1126/science.7878464
  31. Westin P, Bergh A, Damber JE. Castration rapidly results in a major reduction in epithelial cell numbers in the rat prostate, but in the highly differentiated Dunning R332u prostatic adenocarcinoma. Prostate. 1993. 22: 65-75. https://doi.org/10.1002/pros.2990220109
  32. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jone DP, Wang X. Prevention of apoptoisis by bcl-2: release of cytochrome c from mitochondria blocked. Science. 1997. 275: 1129-1132. https://doi.org/10.1126/science.275.5303.1129